Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Pharmaceutical company funding and its consequences: a qualitative systematic review.

Sismondo S.

Contemp Clin Trials. 2008 Mar;29(2):109-13. Epub 2007 Aug 16. Review.

PMID:
17919992
[PubMed - indexed for MEDLINE]
2.

Evaluating solutions to sponsorship bias.

Doucet M, Sismondo S.

J Med Ethics. 2008 Aug;34(8):627-30. doi: 10.1136/jme.2007.022467.

PMID:
18667655
[PubMed - indexed for MEDLINE]
3.

Relationship between funding source and conclusion among nutrition-related scientific articles.

Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS.

PLoS Med. 2007 Jan;4(1):e5.

PMID:
17214504
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.

Peppercorn J, Blood E, Winer E, Partridge A.

Cancer. 2007 Apr 1;109(7):1239-46.

PMID:
17326054
[PubMed - indexed for MEDLINE]
Free Article
5.

Association of funding and findings of pharmaceutical research at a meeting of a medical professional society.

Finucane TE, Boult CE.

Am J Med. 2004 Dec 1;117(11):842-5.

PMID:
15589488
[PubMed - indexed for MEDLINE]
6.

How pharmaceutical industry funding affects trial outcomes: causal structures and responses.

Sismondo S.

Soc Sci Med. 2008 May;66(9):1909-14. doi: 10.1016/j.socscimed.2008.01.010. Epub 2008 Mar 4.

PMID:
18299169
[PubMed - indexed for MEDLINE]
7.

Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Lexchin J, Bero LA, Djulbegovic B, Clark O.

BMJ. 2003 May 31;326(7400):1167-70. Review.

PMID:
12775614
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names.

Hochman M, Hochman S, Bor D, McCormick D.

JAMA. 2008 Oct 1;300(13):1544-50. doi: 10.1001/jama.300.13.1544.

PMID:
18827211
[PubMed - indexed for MEDLINE]
9.

Pharmaceutical company-sponsored drug trials: what are we to believe?

Shekelle P.

J Clin Epidemiol. 2010 Feb;63(2):126-7. doi: 10.1016/j.jclinepi.2009.07.014. No abstract available.

PMID:
19836207
[PubMed - indexed for MEDLINE]
10.

Pharmaceutical company-sponsored drug trials: the system is broken.

Gartlehner G, Fleg A.

J Clin Epidemiol. 2010 Feb;63(2):128-9. doi: 10.1016/j.jclinepi.2009.07.015. Epub 2009 Oct 31. No abstract available.

PMID:
19880288
[PubMed - indexed for MEDLINE]
11.

Relationship between drug company funding and outcomes of clinical psychiatric research.

Kelly RE Jr, Cohen LJ, Semple RJ, Bialer P, Lau A, Bodenheimer A, Neustadter E, Barenboim A, Galynker II.

Psychol Med. 2006 Nov;36(11):1647-56. Epub 2006 Aug 8.

PMID:
16893480
[PubMed - indexed for MEDLINE]
12.

Publication bias in the pulmonary/allergy literature: effect of pharmaceutical company sponsorship.

Liss H.

Isr Med Assoc J. 2006 Jul;8(7):451-4.

PMID:
16889157
[PubMed - indexed for MEDLINE]
Free Article
13.

The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig WD, Lieb K.

Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23. Review.

PMID:
20467553
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Disclosure of competing financial interests and role of sponsors in phase III cancer trials.

Tuech JJ, Moutel G, Pessaux P, Thoma V, Schraub S, Herve C.

Eur J Cancer. 2005 Oct;41(15):2237-40. Epub 2005 Apr 14.

PMID:
16214044
[PubMed - indexed for MEDLINE]
15.

Conflict of interest in industry-sponsored economic evaluations: real or imagined?

Barbieri M, Drummond MF.

Curr Oncol Rep. 2001 Sep;3(5):410-3. Review.

PMID:
11489241
[PubMed - indexed for MEDLINE]
16.

Comparative effectiveness reviews and the impact of funding bias.

Gartlehner G, Fleg A.

J Clin Epidemiol. 2010 Jun;63(6):589-90. doi: 10.1016/j.jclinepi.2010.01.004. No abstract available.

PMID:
20434022
[PubMed - indexed for MEDLINE]
17.

[Research in the pharmaceutical industry cannot be objective].

Becker-BrĂ¼ser W.

Z Evid Fortbild Qual Gesundhwes. 2010;104(3):183-9. German.

PMID:
20608245
[PubMed - indexed for MEDLINE]
18.

Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.

Nkansah N, Nguyen T, Iraninezhad H, Bero L.

Public Health Nutr. 2009 Oct;12(10):1931-7. doi: 10.1017/S136898000900487X. Epub 2009 Mar 2.

PMID:
19254426
[PubMed - indexed for MEDLINE]
19.

[Clinical researchers and pharmaceutical industry].

Mees EJ.

Ned Tijdschr Geneeskd. 1999 Oct 30;143(44):2217. Dutch. No abstract available.

PMID:
10578416
[PubMed - indexed for MEDLINE]
20.

Drug company payments: Speakers should declare funding.

Taylor MS.

BMJ. 2008 Feb 2;336(7638):234. doi: 10.1136/bmj.39465.455995.3A. No abstract available.

PMID:
18244973
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk